Gsk PLC (GLAXF) — SC 13D/A Filings
All SC 13D/A filings from Gsk PLC. Browse 4 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (4)
-
GSK plc Amends 13D Filing for 23andMe Holding Co.
— Nov 15, 2024 Risk: medium
GSK plc filed an amendment (No. 3) to its Schedule 13D on November 15, 2024, concerning its holdings in 23andMe Holding Co. The filing indicates a change in the -
GSK plc Amends Nkarta, Inc. Filing
— Mar 28, 2024 Risk: medium
GSK plc has amended its Schedule 13D filing regarding Nkarta, Inc. on March 28, 2024. The filing indicates a change in beneficial ownership, though specific new -
GSK Amends 23andMe Stake Disclosure on Feb 7 Event
— Feb 9, 2024 Risk: medium
GSK plc, a major pharmaceutical company, filed an Amendment No. 2 to its Schedule 13D on February 9, 2024, indicating a change in its beneficial ownership of 23 -
GSK Amends Haleon Stake Disclosure in SC 13D/A Filing
— Jan 19, 2024
GSK plc filed an Amendment No. 4 to its Schedule 13D on January 19, 2024, regarding its ownership in Haleon plc. This filing updates previous disclosures about
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX